Innovation
Exeliom Biosciences: a new generation of microbiota-derived biotherapies
… a specific bacterium, Faecalibacterium prausnitzii (Fprau), was consistently absent in patients experiencing a relapse but present in those in remission. "That was the beginning of a long story that changed our lives. We … by support from Bpifrance (I-Lab, Deep tech, 2030 Recovery Plan) and the H2020 programme, a highly selective European …
Published on: